Rabbit Polyclonal c-Fos phospho T325 antibody. Suitable for ChIP, WB, ICC/IF and reacts with Human samples. Cited in 14 publications. Immunogen corresponding to Synthetic Peptide within Human FOS phospho T325.
View Alternative Names
G0S7, FOS, Protein c-Fos, Cellular oncogene fos, G0/G1 switch regulatory protein 7, Proto-oncogene c-Fos, Transcription factor AP-1 subunit c-Fos
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-c-Fos (phospho T325) antibody (AB27793)
Immunofluorescence analysis of c-Fos (phospho T325) was done on 70% confluent log phase HeLa cell treated with 200 nM of PMA for 20 minutes. The cell were fixed with 4% paraformaldehyde for 10 minutes, permeabilized with 0.1% Triton™ X-100 for 10 minutes, and blocked with 1% BSA for 1 hour at room temperature. The cells were labeled with Phosc-Fos (phospho T325)Rabbit Polyclonal Antibody (ab27793) at 2 ug/ml in 0.1% BSA and incubated for 3 hours at room temperature and then labeled with Goat anti-Rabbit IgG (H+L) Secondary Antibody, Alexa Fluor® 488 conjugate at a dilution of 1/2000 for 45 minutes at room temperature (Panel a : green). Nuclei (Panel b : blue) were stained with DAPI. F-actin (Panel c : red) was stained with Alexa Fluor® 555 Rhodamine Phalloidin. Panel d is a merged image showing nuclear and cytoplasmic localization. Panel e is untreated cell with no signal. Panel f represents control cells with no primary antibody to assess background. The images were captured at 60X magnification.
- ChIP
Supplier Data
ChIP - Anti-c-Fos (phospho T325) antibody (AB27793)
Chromatin Immunoprecipitation (ChIP) was performed using Anti-c-Fos (phospho T325) antibody (ab27793) 3 ug on sheared chromatin from 2 million A431 cells treated with EGF (200ng/ml), for 30 minutes. Normal Rabbit IgG was used as a negative IP control. The purified DNA was analyzed by 7500 Fast qPCR system with optimized PCR primer pairs for the promoter of active IL-6, CDKN1A gene, used as positive control target, and the SAT2, used as negative control target. Data is presented as fold enrichment of the antibody signal versus the negative control IgG using the comparative CT method.
- WB
Unknown
Western blot - Anti-c-Fos (phospho T325) antibody (AB27793)
The figure shows that the phosphorylation of cFos on threonine 325 is induced by EGF treatment and that Lambda phosphatase treatment eliminates the signal, thereby demonstrating the phospho specificity of ab27793.
All lanes:
Western blot - Anti-c-Fos (phospho T325) antibody (ab27793) at 1/1000 dilution
Lane 1:
Non EGF treated A431 cell lysate
Lane 2:
EGF treated A431 cell lysate
Lane 3:
EGF treated A431 cell lysate treated with Lambda phosphatase
Secondary
All lanes:
goat F(ab’)2 anti rabbit IgG HRP conjugate
Predicted band size: 41 kDa
Observed band size: 58 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
C-Fos acts as part of the Activator Protein-1 (AP-1) complex a group of DNA-binding proteins that regulate gene transcription. This complex forms when c-Fos and Jun proteins dimerize. The AP-1 complex controls several cellular processes such as proliferation differentiation and apoptosis. Due to its participation in these vital processes c-Fos influences cellular responses to external stimuli and can affect how cells behave under stress.
Pathways
C-Fos significantly contributes to the MAPK/ERK pathway which plays a role in cell growth and differentiation. It partners with Jun proteins to form functional transcription factors within the MAPK signaling cascade. Additionally c-Fos is involved in the JNK signaling pathway linking it to stress responses and apoptosis. These pathways highlight the partnerships between c-Fos and other proteins like ERK and JNK indicating their intertwined roles in cellular signaling networks.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (14)
Recent publications for all applications. Explore the full list and refine your search
Journal of ovarian research 16:144 PubMed37480147
2023
Applications
Unspecified application
Species
Unspecified reactive species
Bone research 10:24 PubMed35232979
2022
Applications
Unspecified application
Species
Unspecified reactive species
BMC complementary medicine and therapies 22:52 PubMed35227255
2022
Applications
Unspecified application
Species
Unspecified reactive species
Biology 11: PubMed35053118
2022
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 11:21159 PubMed34707101
2021
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 24: PubMed34278468
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal of biochemical and molecular toxicology 34:e22493 PubMed32319158
2020
Applications
Unspecified application
Species
Unspecified reactive species
Chemico-biological interactions 315:108866 PubMed31669319
2019
Applications
Unspecified application
Species
Unspecified reactive species
International journal of oncology 54:443-454 PubMed30483762
2018
Applications
Unspecified application
Species
Unspecified reactive species
Oncotarget 8:38767-38779 PubMed28404976
2017
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com